The CSO at Aptamer group spoke recently in an interview with BioPharma APAC about Neuro-Bio’s ongoing partnership in which to develop Optimer binders to enable a lateral flow test for the early detection of Alzheimer’s disease. He also covered how a move...
Baroness Susan Greenfield sharing her perspective with Esther Reynal de St Michel Richardot on these important topics: Healthcare-related challenges that policy making is trying to address How it is impacting how innovations can reach patients The importance of having...
At Neuro-Bio, we’re thrilled at entering this next phase of development with Aptamer Group: the first phase proved productive and very promising. Now, this next stage takes us closer to realising a highly novel and much needed technology for detecting...
Our CEO Susan Greenfield and Operations Direction Sara Garcia-Rates, joined Xenopat for a face-to-face meeting in Barcelona where they shared the progress made for the Tecniospring Industry project “Development of a T14 Inhibitor for Treatment of ColoRectal Cancer”,...
The event (8th February 2024) is part of Ultima Hora’s conference series titled “Values” and is jointly organised with the University if the Balearic Islands. On this occasion, it is focused on exploring the future of technology, the internet, its...
To read more on the debate and what will be discussed, please click on the links below: https://parliamentlive.tv/Event/Index/944cbedf-d4e1-4b47-9d82-9f5f3762e2a1 https://www.alzheimers.org.uk/sites/default/files/2024-01/240118 Alzheimer%27s Society Briefing –...
